US Stock MarketDetailed Quotes

AGE AgeX Therapeutics

Watchlist
  • 11.1000
  • 0.00000.00%
Close Mar 26 16:00 ET
27.76MMarket Cap-809P/E (TTM)

AgeX Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
317.65%142K
862.50%77K
411.11%46K
-25.00%9K
100.00%10K
-76.39%34K
-70.37%8K
-62.50%9K
-67.57%12K
-91.07%5K
Operating revenue
317.65%142K
862.50%77K
411.11%46K
-25.00%9K
100.00%10K
-76.39%34K
-70.37%8K
-62.50%9K
-67.57%12K
-91.07%5K
Cost of revenue
207.69%40K
0.00%1K
560.00%33K
-16.67%5K
0.00%1K
-31.58%13K
0.00%1K
150.00%5K
-53.85%6K
-66.67%1K
Gross profit
385.71%102K
685.71%55K
750.00%34K
-33.33%4K
125.00%9K
-83.20%21K
-73.08%7K
-81.82%4K
-75.00%6K
-92.45%4K
Operating expense
43.83%10.06M
103.24%3.64M
52.45%2.37M
18.35%1.89M
5.40%2.17M
-14.31%7M
-5.49%1.79M
-8.37%1.55M
-28.35%1.6M
-12.36%2.06M
Selling and administrative expenses
56.22%9.33M
117.14%3.43M
56.03%2.17M
29.30%1.73M
20.06%1.99M
-10.99%5.97M
4.22%1.58M
-2.04%1.39M
-23.46%1.34M
-17.90%1.66M
-General and administrative expense
56.22%9.33M
117.14%3.43M
56.03%2.17M
29.30%1.73M
20.06%1.99M
-10.99%5.97M
4.22%1.58M
-2.04%1.39M
-23.46%1.34M
-17.90%1.66M
Research and development costs
-28.39%734K
-12.50%182K
34.57%218K
-38.22%160K
-56.06%174K
-29.60%1.03M
-44.68%208K
-41.09%162K
-46.15%259K
22.22%396K
Other operating expenses
----
----
---21K
----
----
----
----
----
----
----
Operating profit
-42.80%-9.96M
-100.95%-3.58M
-50.65%-2.34M
-18.54%-1.89M
-5.17%-2.16M
13.24%-6.98M
4.55%-1.78M
7.41%-1.55M
27.85%-1.59M
10.51%-2.05M
Net non-operating interest income expense
-46.93%-4.9M
102.86%28K
-228.93%-3.04M
8.23%-792K
-92.64%-1.1M
-204.01%-3.34M
-231.53%-978K
-223.86%-923K
-214.96%-863K
-134.98%-571K
Non-operating interest expense
46.93%4.9M
-102.86%-28K
228.93%3.04M
-8.23%792K
92.64%1.1M
204.01%3.34M
231.53%978K
223.86%923K
214.96%863K
134.98%571K
Other net income (expense)
123.11%49K
7,500.00%74K
-91.89%3K
99.39%-1K
67.86%-27K
-138.27%-212K
-133.33%-1K
825.00%37K
-4,200.00%-164K
-115.47%-84K
Gain on sale of security
84.44%-35K
--0
----
97.02%-5K
65.52%-30K
---225K
---5K
--35K
---168K
---87K
Special income (charges)
--73K
----
----
----
----
--0
----
----
----
----
-Gain on sale of property,plant,equipment
--73K
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-15.38%11K
-75.00%1K
50.00%3K
0.00%4K
0.00%3K
-97.10%13K
33.33%4K
-50.00%2K
0.00%4K
-99.31%3K
Income before tax
-40.76%-14.81M
-25.24%-3.46M
-121.22%-5.39M
-2.33%-2.68M
-21.35%-3.29M
-22.61%-10.52M
-27.88%-2.76M
-24.60%-2.44M
-5.78%-2.62M
-35.83%-2.71M
Income tax
Net income
-40.76%-14.81M
-25.24%-3.46M
-121.22%-5.39M
-2.33%-2.68M
-21.35%-3.29M
-21.15%-10.52M
-27.47%-2.76M
-24.60%-2.44M
-5.78%-2.62M
-29.15%-2.71M
Net income continuous Operations
-40.76%-14.81M
-25.24%-3.46M
-121.22%-5.39M
-2.33%-2.68M
-21.35%-3.29M
-22.61%-10.52M
-27.88%-2.76M
-24.60%-2.44M
-5.78%-2.62M
-35.83%-2.71M
Minority interest income
86.67%-8K
96.55%-2K
1,300.00%12K
-10K
-700.00%-8K
-500.00%-60K
-625.00%-58K
-1K
0
87.50%-1K
Net income attributable to the parent company
-41.49%-14.8M
-27.86%-3.46M
-121.81%-5.4M
-1.95%-2.67M
-21.10%-3.28M
-20.60%-10.46M
-25.25%-2.7M
-24.55%-2.44M
-5.82%-2.62M
-29.60%-2.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-41.49%-14.8M
-27.86%-3.46M
-121.81%-5.4M
-1.95%-2.67M
-21.10%-3.28M
-20.60%-10.46M
-25.25%-2.7M
-24.55%-2.44M
-5.82%-2.62M
-29.60%-2.71M
Basic earnings per share
-41.44%-482.5324
-27.85%-3.2027
-133.33%-4.9238
0.00%-2.4619
-28.57%-3.1653
-4,117.39%-341.149
-18.71%-2.5051
-20.00%-2.1102
0.00%-2.4619
-16.67%-2.4619
Diluted earnings per share
-41.44%-482.5324
-27.85%-3.2027
-133.33%-4.9238
0.00%-2.4619
-28.57%-3.1653
-4,117.39%-341.149
-18.71%-2.5051
-20.00%-2.1102
0.00%-2.4619
-16.67%-2.4619
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 317.65%142K862.50%77K411.11%46K-25.00%9K100.00%10K-76.39%34K-70.37%8K-62.50%9K-67.57%12K-91.07%5K
Operating revenue 317.65%142K862.50%77K411.11%46K-25.00%9K100.00%10K-76.39%34K-70.37%8K-62.50%9K-67.57%12K-91.07%5K
Cost of revenue 207.69%40K0.00%1K560.00%33K-16.67%5K0.00%1K-31.58%13K0.00%1K150.00%5K-53.85%6K-66.67%1K
Gross profit 385.71%102K685.71%55K750.00%34K-33.33%4K125.00%9K-83.20%21K-73.08%7K-81.82%4K-75.00%6K-92.45%4K
Operating expense 43.83%10.06M103.24%3.64M52.45%2.37M18.35%1.89M5.40%2.17M-14.31%7M-5.49%1.79M-8.37%1.55M-28.35%1.6M-12.36%2.06M
Selling and administrative expenses 56.22%9.33M117.14%3.43M56.03%2.17M29.30%1.73M20.06%1.99M-10.99%5.97M4.22%1.58M-2.04%1.39M-23.46%1.34M-17.90%1.66M
-General and administrative expense 56.22%9.33M117.14%3.43M56.03%2.17M29.30%1.73M20.06%1.99M-10.99%5.97M4.22%1.58M-2.04%1.39M-23.46%1.34M-17.90%1.66M
Research and development costs -28.39%734K-12.50%182K34.57%218K-38.22%160K-56.06%174K-29.60%1.03M-44.68%208K-41.09%162K-46.15%259K22.22%396K
Other operating expenses -----------21K----------------------------
Operating profit -42.80%-9.96M-100.95%-3.58M-50.65%-2.34M-18.54%-1.89M-5.17%-2.16M13.24%-6.98M4.55%-1.78M7.41%-1.55M27.85%-1.59M10.51%-2.05M
Net non-operating interest income expense -46.93%-4.9M102.86%28K-228.93%-3.04M8.23%-792K-92.64%-1.1M-204.01%-3.34M-231.53%-978K-223.86%-923K-214.96%-863K-134.98%-571K
Non-operating interest expense 46.93%4.9M-102.86%-28K228.93%3.04M-8.23%792K92.64%1.1M204.01%3.34M231.53%978K223.86%923K214.96%863K134.98%571K
Other net income (expense) 123.11%49K7,500.00%74K-91.89%3K99.39%-1K67.86%-27K-138.27%-212K-133.33%-1K825.00%37K-4,200.00%-164K-115.47%-84K
Gain on sale of security 84.44%-35K--0----97.02%-5K65.52%-30K---225K---5K--35K---168K---87K
Special income (charges) --73K------------------0----------------
-Gain on sale of property,plant,equipment --73K------------------0----------------
Other non- operating income (expenses) -15.38%11K-75.00%1K50.00%3K0.00%4K0.00%3K-97.10%13K33.33%4K-50.00%2K0.00%4K-99.31%3K
Income before tax -40.76%-14.81M-25.24%-3.46M-121.22%-5.39M-2.33%-2.68M-21.35%-3.29M-22.61%-10.52M-27.88%-2.76M-24.60%-2.44M-5.78%-2.62M-35.83%-2.71M
Income tax
Net income -40.76%-14.81M-25.24%-3.46M-121.22%-5.39M-2.33%-2.68M-21.35%-3.29M-21.15%-10.52M-27.47%-2.76M-24.60%-2.44M-5.78%-2.62M-29.15%-2.71M
Net income continuous Operations -40.76%-14.81M-25.24%-3.46M-121.22%-5.39M-2.33%-2.68M-21.35%-3.29M-22.61%-10.52M-27.88%-2.76M-24.60%-2.44M-5.78%-2.62M-35.83%-2.71M
Minority interest income 86.67%-8K96.55%-2K1,300.00%12K-10K-700.00%-8K-500.00%-60K-625.00%-58K-1K087.50%-1K
Net income attributable to the parent company -41.49%-14.8M-27.86%-3.46M-121.81%-5.4M-1.95%-2.67M-21.10%-3.28M-20.60%-10.46M-25.25%-2.7M-24.55%-2.44M-5.82%-2.62M-29.60%-2.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -41.49%-14.8M-27.86%-3.46M-121.81%-5.4M-1.95%-2.67M-21.10%-3.28M-20.60%-10.46M-25.25%-2.7M-24.55%-2.44M-5.82%-2.62M-29.60%-2.71M
Basic earnings per share -41.44%-482.5324-27.85%-3.2027-133.33%-4.92380.00%-2.4619-28.57%-3.1653-4,117.39%-341.149-18.71%-2.5051-20.00%-2.11020.00%-2.4619-16.67%-2.4619
Diluted earnings per share -41.44%-482.5324-27.85%-3.2027-133.33%-4.92380.00%-2.4619-28.57%-3.1653-4,117.39%-341.149-18.71%-2.5051-20.00%-2.11020.00%-2.4619-16.67%-2.4619
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg